ACH
CLBT icon

ArrowMark Colorado Holdings’s Cellebrite CLBT Stock Holding History

ArrowMark Colorado Holdings’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.6M Buy
1,497,333
+414,373
+38% +$6.25M 0.55% 56
2025
Q4 		$19.5M Sell
1,082,960
-244,922
-18% -$4.4M 0.43% 68
2025
Q3 		$24.6M Buy
1,327,882
+63,599
+5% +$999K 0.46% 68
2025
Q2 		$20.2M Buy
+1,264,283
New +$22.5M 0.36% 79

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ArrowMark Colorado Holdings's CLBT Position: Q1 2026 in Review

ArrowMark Colorado Holdings increased its Cellebrite (CLBT) stake by 38% in Q1 2026, buying an estimated $6.25M and bringing the position to 1,497,333 shares worth $20.6M. The position accounts for 0.55% of the portfolio, ranked #56.

ArrowMark Colorado Holdings first reported a position in CLBT in Q2 2025 and has held it in 4 quarters since. The position peaked at $24.6M in Q3 2025. 220 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • ArrowMark Colorado Holdings held 1,497,333 shares of Cellebrite worth $20.6M as of Q1 2026.
  • ArrowMark Colorado Holdings bought 414,373 Cellebrite shares in Q1 2026, an estimated $6.25M.
  • Cellebrite made up 0.55% of ArrowMark Colorado Holdings's portfolio in Q1 2026, its #56 holding.
  • ArrowMark Colorado Holdings first reported a position in Cellebrite in Q2 2025 and has held it in 4 quarters since.
  • ArrowMark Colorado Holdings's Cellebrite position peaked at $24.6M in Q3 2025.
  • 220 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on ArrowMark Colorado Holdings's 13F filing for Q1 2026, filed 15 May 2026.